BioSpace News Archive

Cambridge Allergy Ltd, a biopharmaceutical company dedicated to providing innovative, patient-centric treatments for life-threatening food allergies, announced it has been awarded £1.1M funding under the Innovate UK Biomedical Catalyst Award program administered by Innovate UK, the United Kingdom’s research and innovation agency.

Heart block is a disease of the electrical system of the heart that controls the rate and rhythm of the heart. A heart block occurs if there is slowed and disturbed electrical signals while travelling to the heart.

Sterilizing filtration is the process of removing microorganisms from a fluid stream without adversely affecting the product. Objectives of sterile filtration are safety of patients or users, minimize risk for patients, and development of more viable products with no harmful effects.

Thermometers are used in range of applications from medical, industrial, to research areas. The thermometers market has over the past few years made strides and they have become more sophisticated the design as well as functionality.

IRLAB announced that the first patients in Europe have been dosed in the clinical Phase IIb/III study with mesdopetam.

Agilent Technologies Inc., announced that Dr. Katharine Knobil is joining Agilent as the company’s chief medical officer.

Recent trends in the direct-to-consumer (DTC) genetic testing market are driven by an increase in the number of product developments by prominent industry participants.

Increasing indispensable technology use through smartphones by insurers, patients, and physicians to share, access, as well as receive information will boost the business share.

As the world is witnessing rising prevalence of bone and joint disorders, demand for efficient surgical and treatment solutions like joint reconstruction procedures has also increased enormously.

Rising public awareness about preventive care could generate new growth strides in the orthopedic support systems market over the coming years.